Related Experiment Video
Updated: Jul 13, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
[Clinical significance of sulfate-reducing bacteria for ulcerative colitis]
Kunitomo Watanabe1, Hiroshige Mikamo, Kaori Tanaka
1Division of Anaerobe Research, Life Science Research Center, Gifu University.
Abstract:
Ulcerative colitis(UC) is colon localized disease. Broad epithelial cell damage, crypt abscesses and accumulation of neutrophils are recognized for UC. Although the cause of UC is indistinct at this time, there is a growing consensus that abnormal intestinal microflora would be related with UC. There have been several evidences that excessive production of hydrogen sulfide by bacteria in colon would be associated with UC. Sulfate reducing bacteria are able to utilize sulfate as an electron receptor for dissimilation of organic substrate and hydrogen gas, resulting in generating toxic hydrogen sulfide. This review is dealt with the association between sulfate reducing bacteria and UC in aetiology and bacterial pathogenesis.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Sulfur Assimilation
Inflammatory Bowel Disease II: Ulcerative Colitis
Microbes and the Sulfur Cycle
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

